CheckRare

CheckRare is a pioneering digital publisher and learning platform dedicated exclusively to rare diseases and rare cancers. With a mission to enhance patient outcomes through awareness and education, CheckRare serves both healthcare providers and patients. The organization provides a comprehensive suite of resources that include the latest insights on rare diseases, orphan drugs, current and emerging treatments, and clinical trial updates.

Recognizing that rare diseases affect over 30 million Americans, CheckRare is committed to raising awareness and delivering crucial information to patients, caregivers, and healthcare professionals. The platform features original content, editorial contributions from industry experts, and certified education programs developed in partnership with the American Academy of CME.

CheckRare acknowledges the complexities of rare diseases, boasting a unique perspective that combines patient experiences with scientific insight. With no charge for registration, the platform fosters a supportive community where users can access reliable, easy-to-understand information tailored to their needs. Through its dedication to education and advocacy, CheckRare continues to make significant strides in improving the lives of those impacted by rare conditions.